MoneyWorks4Me

Orchid Chemicals initiates process for restructuring its debt

24 Jun 2013 Evaluate

Orchid Chemicals and Pharmaceuticals has initiated the process of restructuring its debt due to continuing liquidity constraints and pressure on operations. Accordingly the company has made reference to the Corporate Debt Restructuring Cell (CDR Cell) through State Bank of India (SBI).

Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Peers
Company Name CMP
Sun Pharma. Inds. 1846.30
Dr. Reddys Labs. 1147.45
Cipla 1359.20
Lupin 2050.80
Zydus Lifesciences 1108.25
View more..